rs12593008 — LIPC

LIPC rs12593008 — Intron 1 Variant and Sex-Specific HDL Risk

Hepatic lipase (HL), the enzyme encoded by the LIPC gene on chromosome 15q21-22, governs the final stage of lipoprotein particle remodeling in the liver. It hydrolyzes triglycerides and phospholipids from HDL2, converting the large, buoyant particles into smaller, denser HDL3 — the form most capable of capturing cholesterol from arterial walls. HL also clears intermediate-density lipoprotein (IDL) and triglyceride-rich VLDL remnants. The net result is that HL activity shapes not just your total HDL-cholesterol number but the composition and functional quality of those particles. The LIPC locus is among the most consistently replicated GWAS signals for HDL-cholesterol in the human genome.

rs12593008 is located in intron 1 of LIPC (GRCh38 chr15:58,468,776, C>A). It lies within a haplotype block that includes the well-studied promoter variants rs1800588 (-514C>T), rs2070895 (-250G>A), and the eQTL signal rs1532085. These variants are in moderate to high linkage disequilibrium and collectively tag a regulatory haplotype that modulates hepatic lipase expression. rs12593008 itself may tag the functional effect through LD rather than acting as the causal variant.

The Mechanism

The C allele at rs12593008 tracks with reduced hepatic lipase activity within the intron 1 / promoter haplotype context. Carriers of the CC genotype show lower HL activity — impairing conversion of HDL2 to HDL3 and slowing clearance of IDL and VLDL remnants. The result is a tendency toward lower total HDL-cholesterol alongside elevated triglycerides. Unlike the A-allele genotypes at rs1532085 (which paradoxically raise total HDL-C while impairing HDL function), the rs12593008 C allele risk profile at this locus is directionally consistent with the classic low-HDL phenotype seen in hepatic lipase deficiency states.

Sex hormones modulate hepatic lipase expression directly — estrogen suppresses HL activity and testosterone stimulates it. This hormonal influence explains why the genetic signal at rs12593008 is stronger in women, where the background HL activity is already lower, amplifying the contribution of inherited variants.

The Evidence

The primary association for rs12593008 itself comes from a family-based linkage and association study by Feitosa et al. (2009)¹¹ Feitosa et al. (2009), which examined 19 tag-SNPs across ~140 kb of the LIPC locus in 591 families (2,238 subjects) from the NHLBI Family Heart Study. The intron 1 SNP rs12593008 showed strong sex-specific association: in women, the A allele (AC or AA genotypes) was associated with a significantly decreased risk of low HDL (p=0.00217, q=0.0412 by TRANSMIT; p=0.02461 by FBAT). The effect was weaker and non-significant in men. A related promoter SNP, rs261342, showed the strongest absolute effect in women — the less common allele associated with ~14% higher HDL-C and ~30% lower risk of low HDL. Because rs261342 and rs12593008 reside within the same haplotype block, the two signals are correlated and likely capture overlapping biological variation.

The broader LIPC locus context is well established. The Teslovich et al. 2010 Nature meta-analysis²² Teslovich et al. 2010 Nature meta-analysis of more than 100,000 Europeans identified the LIPC region as a genome-wide significant HDL-C locus (P=9.7×10⁻³⁶), one of the strongest signals in the lipid genome. A Mendelian randomization analysis by Silbernagel et al. (2019)³³ Mendelian randomization analysis by Silbernagel et al. (2019) found that lower hepatic lipase activity causally increases cardiovascular risk, with individuals in the highest LDL-triglyceride quintile (a read-out of HL impairment) showing a hazard ratio of 2.53 for cardiovascular mortality compared to the lowest quintile (9.9-year follow-up, p<0.001).

An important gene-diet interaction documented at this locus: Ordovas et al. (2002, Framingham Study)⁴⁴ Ordovas et al. (2002, Framingham Study) showed that LIPC promoter variants closely related to the intron 1 haplotype exert diet-dependent effects — the T allele (associated with lower HL activity, analogous to the A allele here) raised HDL-C significantly only when dietary fat was below 30% of total energy. At ≥30% dietary fat — particularly saturated and monounsaturated fat — this benefit reversed, with those individuals showing the lowest HDL-C of any genotype group.

The statin connection: Lahoz et al. (2005)⁵⁵ Lahoz et al. (2005) found that the LIPC -514C/T (rs1800588) variant, in high LD with this locus, modifies the HDL-C response to pravastatin. T allele carriers gained 6.9% in HDL-C versus 0.8% in CC homozygotes (p=0.019), suggesting that LIPC haplotype status is relevant when predicting individual statin response on HDL.

Practical Actions

For CC genotype individuals, the actionable priorities are: (1) keep dietary saturated fat low to avoid compounding HL-mediated HDL suppression; (2) monitor fasting HDL-C and triglycerides together since the two metrics co-vary in this locus; (3) if on statins, note that LIPC haplotype influences HDL response to treatment.

For AC genotype carriers, the single A allele confers intermediate protection — the gene-diet interaction data still applies, meaning saturated fat intake should be moderated to preserve whatever HDL advantage the A allele provides.

Interactions

rs12593008 lies within the same haplotype block as rs1532085 (the LIPC eQTL hub), rs1800588 (-514C>T promoter), rs2070895 (-250G>A), and rs261342. Genetic panels may report any one of these; their effects are mechanistically convergent through shared hepatic lipase expression regulation. If multiple LIPC variants are reported on a test, rs1532085 is the better-powered estimate of the regulatory signal.

CETP gene variants (particularly rs708272) interact additively with LIPC locus variants to further raise HDL-C, but the combined effect on cardiovascular endpoints appears driven primarily by the CETP side. The rs1532085–HMGCR interaction (documented in Ma et al. 2012) identifies an additional gene-gene signal worth noting in individuals on statin therapy.